Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment.

Disseminated tumor cells must negotiate multiple situations that challenge their viability and/or proliferative capacity before they can successfully colonize distant organ sites. Thus, the shear stress caused by the blood flow may physically damage tumor cells during their translocation from primary tumors to distant organs via the circulation. In addition, the tissue microenvironment of distant organs is generally unfamiliar to tumor cells, limiting their proliferation within the parenchyma of these organs. Each of these situations involves various types of interactions between tumor cells and host components, which either support or inhibit the establishment and subsequent progression of metastases. The initial formation of micrometastases, as well as their subsequent growth--often termed colonization--therefore require complex adaptations by tumor cells to various host components, most of which are never encountered by these cells during their growth within primary tumor sites. These difficulties explain why the colonization of distant organs by disseminated tumor cells is an extraordinarily demanding task and thus inefficient, and suggests a number of potential targets that might be used in the future to interfere therapeutically with this process. Studying the details of tumor-host interactions at each of the steps leading up to successful metastatic colonization may therefore pave the way for designing therapeutic strategies to counteract the metastatic spread of malignant tumors.

[1]  Hiroyuki Aburatani,et al.  Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis , 2006, Nature Cell Biology.

[2]  Steven Patierno,et al.  Tissue factor, thrombin, and cancer. , 2003, Chest.

[3]  Jeffrey W. Pollard,et al.  Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.

[4]  J. Abastado,et al.  Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. , 2010, The Journal of clinical investigation.

[5]  William C. Aird,et al.  Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms , 2007, Circulation research.

[6]  I. Stamenkovic,et al.  Induction of Apoptosis of Metastatic Mammary Carcinoma Cells In Vivo by Disruption of Tumor Cell Surface CD44 Function , 1997, The Journal of experimental medicine.

[7]  Mina J Bissell,et al.  Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. , 2008, Seminars in cancer biology.

[8]  D Hölzel,et al.  The process of metastasisation for breast cancer. , 2003, European journal of cancer.

[9]  S. Rafii,et al.  VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche , 2005, Nature.

[10]  E Ruoslahti,et al.  Integrin signaling. , 1999, Science.

[11]  K. Honn,et al.  Enhanced tumor cell adhesion to the subendothelial matrix resulting from 12(S)‐HETE‐induced endothelial cell retraction , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  J. Haier,et al.  The tumor cell–host organ interface in the early onset of metastatic organ colonisation , 2007, Clinical & Experimental Metastasis.

[13]  A. Al-Mehdi,et al.  Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis , 2000, Nature Medicine.

[14]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[15]  M. Monden,et al.  Cancer Cells Cause Vascular Endothelial Cell (vEC) Retraction via 12(S)HETE Secretion; The Possible Role of Cancer Cell Derived Microparticle , 2007, Annals of Surgical Oncology.

[16]  G. Roodman Mechanisms of bone metastasis. , 2004, Discovery medicine.

[17]  G. Randolph,et al.  Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes , 1999, Journal of leukocyte biology.

[18]  J. Erler,et al.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. , 2009, Cancer cell.

[19]  I. Bross,et al.  The metastatic spread of myeloma and leukemias in men , 2004, Virchows Archiv A.

[20]  B. Klaunberg,et al.  Immune Evasion by Murine Melanoma Mediated through CC Chemokine Receptor-10 , 2003, The Journal of experimental medicine.

[21]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[22]  R. Weinberg,et al.  Correction for Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs, by Tsukasa Shibue and Robert A. Weinberg, which , 2009 .

[23]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[24]  D. Nance,et al.  Interactions between cancer cells and the endothelium in metastasis , 2000, The Journal of pathology.

[25]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[26]  Monika Sramkova,et al.  Intravital microscopy: a novel tool to study cell biology in living animals , 2010, Histochemistry and Cell Biology.

[27]  G. Hollweg,et al.  Tumour-cell-endothelial interactions: free radicals are mediators of melanoma-induced endothelial cell damage , 1996, Virchows Archiv.

[28]  P. Gassmann,et al.  Organ-specific metastatic tumor cell adhesion and extravasation of colon carcinoma cells with different metastatic potential. , 2006, The American journal of pathology.

[29]  S. Lockett,et al.  Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. , 2008, Cancer research.

[30]  R. Weinberg,et al.  Systemic Endocrine Instigation of Indolent Tumor Growth Requires Osteopontin , 2008, Cell.

[31]  J E Talmadge,et al.  Evidence for the clonal origin of spontaneous metastases. , 1982, Science.

[32]  C. Klein,et al.  Parallel progression of primary tumours and metastases , 2009, Nature Reviews Cancer.

[33]  David A. Cheresh,et al.  Integrins in cancer: biological implications and therapeutic opportunities , 2010, Nature Reviews Cancer.

[34]  K. Pienta,et al.  Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line. , 1998, Journal of the National Cancer Institute.

[35]  E. Ruoslahti,et al.  Metadherin, a cell surface protein in breast tumors that mediates lung metastasis. , 2004, Cancer cell.

[36]  I. Macdonald,et al.  Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth , 1994, Clinical & Experimental Metastasis.

[37]  Ruth J. Muschel,et al.  Coagulation Facilitates Tumor Cell Spreading in the Pulmonary Vasculature during Early Metastatic Colony Formation , 2004, Cancer Research.

[38]  J. Kutok,et al.  Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin , 2004, Cancer Research.

[39]  F. Orr,et al.  Quantification and morphologic demonstration of reactive oxygen species produced by Walker 256 tumor cells in vitro and during metastasis in vivo. , 1994, Laboratory investigation; a journal of technical methods and pathology.

[40]  S. Simon,et al.  Molecular mechanics and dynamics of leukocyte recruitment during inflammation. , 2005, Annual review of biomedical engineering.

[41]  M. Raderer,et al.  Inhibition of metastases by anticoagulants. , 1999, Journal of the National Cancer Institute.

[42]  S. Coughlin,et al.  Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. , 2004, Blood.

[43]  K. Luzzi,et al.  Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. , 1998, The American journal of pathology.

[44]  K. Pienta,et al.  Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. , 2005, Neoplasia.

[45]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[46]  F. Orr,et al.  Interactions of cancer cells with the microvasculature during metastasis 1 2 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[47]  D. Cheresh,et al.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis , 2004, The Journal of cell biology.

[48]  A. Saqi,et al.  Pulmonary tumor embolism: a review of the literature. , 2003, The American journal of medicine.

[49]  W. Falk,et al.  GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice , 2004, Clinical & Experimental Metastasis.

[50]  M. Smyth,et al.  Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells , 2001, Nature Medicine.

[51]  Kenneth L. van Golen,et al.  Stepping out of the flow: capillary extravasation in cancer metastasis , 2007, Clinical & Experimental Metastasis.

[52]  Tae-Hee Lee,et al.  Vascular Endothelial Growth Factor Modulates the Transendothelial Migration of MDA-MB-231 Breast Cancer Cells through Regulation of Brain Microvascular Endothelial Cell Permeability* , 2003, The Journal of Biological Chemistry.

[53]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[54]  G. Mundy Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities , 2002, Nature Reviews Cancer.

[55]  M. Tatematsu,et al.  Real‐time observation of micrometastasis formation in the living mouse liver using a green fluorescent protein gene–tagged rat tongue carcinoma cell line , 2001, International journal of cancer.

[56]  J. Tímár,et al.  Tumor cell-derived 12(S)-hydroxyeicosatetraenoic acid induces microvascular endothelial cell retraction. , 1994, Cancer research.

[57]  I. Fidler,et al.  Therapy of cancer metastasis by tumoricidal activation of tissue macrophages using liposome-encapsulated immunomodulators. , 1998, Pharmacology & therapeutics.

[58]  Tanja Fehm,et al.  Circulating Tumor Cells in Patients with Breast Cancer Dormancy , 2004, Clinical Cancer Research.

[59]  M. Gandhi,et al.  Donor derived malignancy following transplantation: a review , 2007, Cell and Tissue Banking.

[60]  N. Senninger,et al.  An intravital model to monitor steps of metastatic tumor cell adhesion within the hepatic microcirculation , 2003, Journal of Gastrointestinal Surgery.

[61]  Konstantinos Konstantopoulos,et al.  Cancer cells in transit: the vascular interactions of tumor cells. , 2009, Annual review of biomedical engineering.

[62]  Paula D. Bos,et al.  Mediators of vascular remodelling co-opted for sequential steps in lung metastasis , 2007, Nature.

[63]  E. Dejana,et al.  Involvement of the very late antigen 4 integrin on melanoma in interleukin 1-augmented experimental metastases. , 1995, Cancer research.

[64]  A. Varki,et al.  P-selectin deficiency attenuates tumor growth and metastasis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[65]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[66]  K. Honn,et al.  Protein kinase C-dependent effects of 12(S)-HETE on endothelial cell vitronectin receptor and fibronectin receptor , 1993, The Journal of cell biology.

[67]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[68]  T. Giordano,et al.  NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF , 2007, Nature Medicine.

[69]  F. Entschladen,et al.  Extravasation of leukocytes in comparison to tumor cells , 2008, Cell Communication and Signaling.

[70]  N. Clarke,et al.  bone marrow endothelium: binding , 2022 .

[71]  L. Liotta,et al.  The significance of hematogenous tumor cell clumps in the metastatic process. , 1976, Cancer research.

[72]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[73]  Wenjun Guo,et al.  Integrin signalling during tumour progression , 2004, Nature Reviews Molecular Cell Biology.

[74]  W. Gerald,et al.  Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. , 2005, The Journal of clinical investigation.

[75]  K. Miyake,et al.  Involvement of very late activation antigen 4 (VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) in tumor necrosis factor alpha enhancement of experimental metastasis. , 1994, Cancer research.

[76]  Meng Yang,et al.  The role of the intravascular microenvironment in spontaneous metastasis development , 2010, International journal of cancer.

[77]  G. Naumov,et al.  Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. , 2002, Cancer research.

[78]  J. Folkman,et al.  Heterogeneity of angiogenic activity in a human liposarcoma: a proposed mechanism for "no take" of human tumors in mice. , 2001, Journal of the National Cancer Institute.

[79]  D. Amadori,et al.  Pathogenesis of osteoblastic bone metastases from prostate cancer , 2010, Cancer.

[80]  G. Nicolson,et al.  Interactions of tumor cells with vascular endothelial cell monolayers: a model for metastatic invasion. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[81]  A. Chambers,et al.  Tumor dormancy and metastasis. , 2009, Advances in cancer research.